IDEAYA Biosciences Ownership | Who Owns IDEAYA Biosciences?
IDEAYA Biosciences Ownership Summary
IDEAYA Biosciences is owned by 58.15% institutional investors, 0.90% insiders, and 40.95% retail investors. Fmr is the largest institutional shareholder, holding 14.86% of IDYA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.73% of its assets in IDEAYA Biosciences shares.
IDYA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | IDEAYA Biosciences | 58.15% | 0.90% | 40.95% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 13.15M | 14.86% | $357.72M |
| Blackrock funding, inc. /de | 8.21M | 9.16% | $283.80M |
| Blackrock | 6.81M | 8.73% | $239.02M |
| Janus henderson group | 5.86M | 6.80% | $150.61M |
| Capital research global investors | 5.28M | 5.89% | $182.52M |
| Vanguard group | 5.02M | 5.60% | $173.52M |
| Point72 asset management | 3.82M | 4.31% | $103.83M |
| Federated hermes | 3.40M | 3.79% | $117.39M |
| Baker bros. advisors lp | 3.28M | 3.70% | $89.12M |
| State street | 3.24M | 3.66% | $88.19M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gsk | 1.33M | 5.77% | $46.09M |
| Logos global management lp | 2.25M | 5.49% | $61.22M |
| Boxer capital | 2.20M | 4.07% | $77.34M |
| Dafna capital management | 539.92K | 3.63% | $14.69M |
| Stempoint capital lp | 371.82K | 2.03% | $10.12M |
| Redmile group | 742.02K | 1.96% | $20.19M |
| Sofinnova investments | 922.70K | 1.37% | $25.11M |
| Healthinvest partners ab | 97.44K | 1.07% | $3.37M |
| Iron triangle partners lp | 270.00K | 1.04% | $7.35M |
| Fifth lane capital, lp | 34.24K | 0.94% | $931.59K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 2.90M | 0.13% | 1.66M |
| Gsk | 1.33M | 5.77% | 1.33M |
| Baker bros. advisors lp | 3.28M | 0.64% | 1.16M |
| Blackrock | 6.81M | 0.01% | 842.38K |
| Janus henderson group | 5.86M | 0.08% | 695.26K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 2.15M | 0.89% | -1.76M |
| Bvf inc/il | - | - | -1.41M |
| Ra capital management | - | - | -1.35M |
| Capital research global investors | 5.28M | 0.03% | -1.27M |
| Federated hermes | 3.40M | 0.20% | -1.23M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gsk | 1.33M | 5.77% | 1.33M | $46.09M |
| Tang capital management | 400.00K | 0.42% | 400.00K | $10.88M |
| Axa investment managers | 325.51K | 0.02% | 325.51K | $8.86M |
| Iron triangle partners lp | 270.00K | 1.04% | 270.00K | $7.35M |
| Susquehanna portfolio strategies | 163.26K | 0.07% | 163.26K | $4.44M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -1.00 |
| Skopos labs | -4.00 |
| Jpl wealth management | -10.00 |
| Geneos wealth management | -15.00 |
| Cibc private wealth group | -16.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 179 | -21.15% | 52,131,217 | -44.59% | 58 | 0.51% | 101 | -20.47% | 49 | -27.94% |
| Sep 30, 2025 | 218 | 5.83% | 92,968,998 | -3.97% | 105 | 0.88% | 123 | 16.04% | 67 | -11.84% |
| Jun 30, 2025 | 205 | -0.97% | 96,799,776 | 3.14% | 109 | 0.97% | 105 | -20.45% | 76 | 61.70% |
| Mar 31, 2025 | 13 | -93.69% | 10,891,961 | -88.15% | 12 | 0.11% | 8 | -93.65% | 2 | -96.36% |
| Dec 31, 2024 | 104 | -51.17% | 47,415,335 | -48.39% | 55 | 0.48% | 63 | -55.63% | 28 | -36.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.91M | 6.73% | 27.31K |
| Fidelity Growth Compy Commingled Pl O | 5.35M | 6.33% | 82.95K |
| American Funds SMALLCAP World A | 4.79M | 5.46% | -1.08M |
| Fidelity Growth Company Fund | 4.16M | 4.73% | -23.43K |
| Vanguard Total Stock Mkt Idx Inv | 2.64M | 3.01% | 9.78K |
| Vanguard US Total Market Shares ETF | 2.49M | 2.85% | 2.78K |
| State Street® SPDR® S&P® Biotech ETF | 2.18M | 2.48% | -11.66K |
| Federated Hermes Kaufmann Growth | 2.01M | 2.29% | -687.50K |
| Federated Hermes Kaufmann R | 2.01M | 2.29% | -687.50K |
| iShares Russell 2000 ETF | 1.93M | 2.19% | 1.18M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 29, 2024 | WHITE MICHAEL ANTHONY | Chief Scientific Officer | Sell | $31.30K |
| May 29, 2024 | WHITE MICHAEL ANTHONY | Chief Scientific Officer | Sell | $1.00M |
| May 16, 2024 | Hata Yujiro S | President and CEO | Sell | $1.26M |
| May 14, 2024 | Hata Yujiro S | President and CEO | Sell | $2.26M |
| May 15, 2024 | Hata Yujiro S | President and CEO | Sell | $2.28M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 9 |
IDYA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools